alizarin has been researched along with Renal Insufficiency, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, A; Dong, Q; Feng, L; Fu, M; Lan, Z; Li, L; Li, Y; Liang, Q; Liu, X; Lu, L; Wang, S; Xie, L; Yan, J; Yang, X; Ye, Y | 1 |
1 other study(ies) available for alizarin and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Sodium-glucose cotransporter 2 inhibitor canagliflozin alleviates vascular calcification through suppression of nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 inflammasome.
Topics: Animals; Canagliflozin; Diabetes Mellitus, Type 2; Glucose; Humans; Inflammasomes; Leucine; Mice; Myocytes, Smooth Muscle; NLR Family, Pyrin Domain-Containing 3 Protein; Nucleotides; Osteogenesis; Pyrin Domain; Rats; Renal Insufficiency, Chronic; Sodium; Vascular Calcification; X-Ray Microtomography | 2023 |